Safe Harbor Financial Signs Opifex Media Term Sheet
SHF Holdings, doing business as Safe Harbor Financial, signed a non-binding term sheet for a combination with Opifex Media Inc., but no financial terms have surfaced.

Street view of a modern glass building in downtown area with reflections, urban life, and city vibes.
A term sheet, not a deal
SHF Holdings, Inc., doing business as Safe Harbor Financial, disclosed a non-binding term sheet with Opifex Media Inc. in a release dated Oct. 29, 2026.
The Denver-datelined release describes Safe Harbor as a fintech platform serving the regulated cannabis and hemp industries. The excerpt CannIntel reviewed cut off mid-sentence while describing Opifex, so the counterparty's business and home base aren't confirmed here.
That's the full verified record. No purchase price, no exchange ratio, no per-share value, no cash-versus-stock split.
What non-binding means for investors
A non-binding term sheet commits neither side to close, which makes it the weakest form of deal announcement. Either party can walk. Either can also reprice or restructure before a definitive agreement is signed.
Term sheets typically set out the broad architecture: who owns what afterward, who sits on the board, and what conditions apply. Exclusivity provisions, if any, are the one piece that sometimes carries legal weight, and the release excerpt doesn't say whether one exists.
Paraphrased, the signal is simple: a term sheet fixes direction, not price, and until a definitive agreement lands, the combination is a stated intention.
Markets tend to price these announcements on the assumption that most, but not all, convert. Without terms, there's nothing to model.
The numbers nobody has published yet
Until Safe Harbor or Opifex discloses valuation and ownership terms, the per-share and EBITDA math can't be run. Four items would let analysts start.
First, the exchange ratio or cash consideration, which sets per-share dilution or premium for current holders. Second, pro forma ownership, which shows who controls the combined company. Third, each side's revenue and adjusted EBITDA contribution. Fourth, any financing attached to the deal, because a combination that needs fresh capital changes the dilution picture entirely.
If Safe Harbor is the acquirer, the question is what it's paying and in what currency. If it's the target, the question flips to the premium. The excerpt doesn't say which.
The strategic logic is unstated
The release excerpt offers no rationale, so any read on why a cannabis fintech would pair with Opifex Media is inference, not reporting.
Here's the inference. Cannabis and hemp operators face two chronic constraints: limited access to conventional financial services and tight limits on advertising reach. A company sitting on the payments and compliance side of that equation has an obvious interest in customer acquisition. Whether Opifex addresses that need isn't something the available text confirms.
The pairing is unusual on its face. Fintech and media rarely share a cost structure, a sales cycle or a regulatory burden. That doesn't make it a bad idea, but it raises the bar for the explanation management owes shareholders.
Not yet an easy story to tell.
What to watch next
The next disclosures to watch are a definitive agreement, an SEC filing with the deal terms, and any investor presentation putting numbers on the combination.
Read any follow-up filing for the sections that matter: the description of the transaction, the risk factors tied to the combination, and the conditions to closing, including any shareholder vote. Cannabis-sector deals also carry diligence on licensing exposure and on how each side's customers are affected by 280E, the tax provision that inflates effective rates for plant-touching operators. For full background as this story develops, see the CannIntel topic hub on the Safe Harbor Financial and Opifex Media combination.
Sector fintech has a long record of announced intentions that never reach a signature, and a Denver-datelined press release isn't a filing. The tell will be whether terms arrive within weeks or the silence stretches on.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

MariMed Stockholders Approve Reverse Split Up to 1-for-100
Shareholders gave MariMed's board discretion over whether and when to consolidate shares at a ratio between 1-for-50 and 1-for-100.

Fernway Vape Brand Says It Leads 3 States, Heads West
Fernway says word of mouth made it the top vape brand in Massachusetts, New Jersey and New York. Its westward move is documented only in one post.

New York Cannabis Sales Top $1.4 Billion Through Q3
MJBizDaily's tally puts New York's legal market past $1.4 billion through the third quarter, a number that says more about scale than profit.
More from the newsroom

NJCRC Approves Special Curaleaf Renewal, Denies Pesticide Request
New Jersey regulators granted Curaleaf an off-track renewal because of litigation and, in a separate ruling, rejected a pesticide-related request, Heady NJ reported.

ASA names 21 recipients of 2026 Cannabis Safety Awards
Americans for Safe Access tied its annual awards to the federal rescheduling debate, but the public excerpt omits recipients, categories and selection criteria.

California Task Force Reports $1.5B in Illegal Cannabis Destroyed
A $1.5 billion destruction tally lands in California's enforcement debate, but the valuation method and hemp-versus-cannabis testing rules behind it remain unclear.